Abstract
Introduction
Chronic kidney disease / chronic renal failure encompasses a spectrum of different pathophysiological processes associated with abnormal kidney function and a progressive decline in glomerular filtration rate (GFR). The term chronic renal failure applies to the process of continuing significant irreversible reduction in nephron number and typically corresponds to CKD stages 3-5. Uremia affects every organ system of body. Central nervous system is commonly affected in uremics. The prevalence of moderate to severe cognitive impairment in hemodialysis patients is more than double the prevalence in the general population. These patients could benefit from cognitive assessment before and periodically after dialysis therapy initiation 1 . Reports of NCCT findings in CRF patients, however, have been less well documented.
Materials and Methods
This is a prospective study for a period of one year from Nov. 2016 to oct. 2017 performed in GMC, Jammu. In the present study 64 patients of chronic kidney disease of either sex fulfilling inclusion criteria were enrolled in the study. 
Results
A total of 64 patients enrolled in our study. All subjects were known cases of CKD (already diagnosed) following Nephrology or General Medicine Outpatient Department at Govt. Medical College, Jammu. The observations made in the study are as under: Most of the patients in the study were in the age group of 41-50 (26; 40.62%). Male to female ratio among the patients was 1.28:1; with males constituting 56.25% and females 43.75%. In the present study of 64 patients of CKD, history of hypertension was present in 58 (85.93%) and history of Diabetes mellitus was present in 39 (60.93%) patients. Most patients presented with chief complaints of drowsiness (35; 54.68%). Most of the patients had stage V CKD (53; 82.81%). Most patients taken in study were on maintenance dialysis (HD) 42; 65.61%. 32 patients (50%) were on hemodialysis and 10 patients (15.62%) were on peritoneal dialysis. Also 22 patients (34.37%) were on conservative treatment. Most common CT Head finding is cerebral atrophy (42; 65.62%). Other findings included bilateral cerebral hypodensities, bilateral basal ganglia hypodensities, ICSOL, etc. Ischemic stroke was seen in 8 patients (12.5%); out of which 5 patients has lacunar infarcts. Haemorrhagic stroke occurred in 6 patients (9.3%). Ischemic stroke with haemorrhagic transformation was seen in 2 patients. Endocranial calcification including bilateral basal ganglia calcifications were seen in 6 patients. Most common site for haemorrhagic stroke was found to be thalamus (3 patients) followed by basal ganglia (2patients) and cerebral cortex (1patient). NCCT Head was reported normal in 10 (15.62%) patients.
Discussion
Neurological system is involved from several pathological conditions like uremic encephalopathy, dementia, stroke, etc. The increasing prevalence of neurological symptoms has resulted in studies on central nervous system lesions via radioimaging like NCCT Head. Dialysis can directly or indirectly be associated with dialysis dementia, disequilibrium syndrome, aggravations of atherosclerosis, cerebrovascular accidents, etc. Out of 64 patients, 53 (82.81%) had CKD Stage V, 7 (10.93%) had CKD Stage IV, 2 (3.12%) had CKD Stage IIIb, 2 (3.12%) had CKD Stage IIIa. 55 patients were hypertensive and 39 were diabetic. All the patients were presenting with neurological complaints like drowsiness, hemiparesis, facial palsy, seizure, sudden syncope, irrelevant talking, etc. On NCCT Head, cerebral atrophy was found in 42 patients (65.62%). Out of 22 patients on conservative treatment, 11 patients had cerebral atrophy (50%). Out of 32 patients on hemodialysis treatment, 24 patients had cerebral atrophy (75%). Out of 10 patients on peritoneal dialysis treatment, 7 had cerebral atrophy (70%). Out of overall 42 patients on dialysis treatment, 31 patients had cerebral atrophy (73.8% 
Conclusion
Neurological manifestations have been frequently reported in patients of chronic renal failure. Patients of CKD have moderate to severe chronic cognitive impairment, yet it is largely undiagnosed. Hemodialysis patients are at high risk of cognitive impairment due to their older age and high prevalence of stroke and cardiovascular risk factors. The early recognition of risk factors associated with stroke in CKD population is imperative. Early interventions may potentially decrease the incidence and associated mortality of stroke in CKD patients (Nadia Kousar et al. 2009) 8 .
